Daily as of 23 Sep 16:00 ET
- Price
- between the two $17.03 vs 50 $16.96 / 200 $17.18
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 4 May 2026 · projected 30 bars out
TBPH | Theravance BiopharmaNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$17.03
$0.00 (0.00%)
Theravance Biopharma (TBPH) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
TBPH stopped trading under this ticker on 23 Sep 2026.
Timeframe summary
Weekly as of 25 Sep 16:00 ET
- Price
- between the two $17.03 vs 50 $17.12 / 200 $11.78
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 25 Aug 2025 · projected 12 bars out
4-hour as of 23 Sep 16:00 ET
- Price
- between the two $17.03 vs 50 $17.03 / 200 $16.80
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 1 Jul 2026 · projected 22 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 1 Jul 2026 | 🟨Golden | 4-hour | 22 bars out | Not tested |
| 4 May 2026 | 💀Death steep | daily | 30 bars out | Not tested |
| 12 Mar 2026 | 💀Death | 4-hour | 15 bars out | Not tested |
| week of 25 Aug 2025 | 🟨Golden moderate | weekly | 12 bars out | Not tested |
| 15 May 2025 | 🟨Golden | 4-hour | 30 bars out | — |
About TBPH
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$7.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall